Log in
Enquire now
Mereo BioPharma

Mereo BioPharma

Mereo BioPharma is an acquisition & rapid development of drugs founded by Charles Sermon, Denise Scots-Knight and John Richard.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
Also Known As
OncoMed Pharmaceuticals
CEO
‌
Denise Scots-Knight
0
CFO
‌
Christine Fox
0
CIK Number
1,719,714
0
Legal Name
Oncomed AB
Company Operating Status
Active
Competitors
OrphAI Therapeutics
OrphAI Therapeutics
0
Country
United Kingdom
United Kingdom
Crunchbase URL
crunchbase.com/organiz...iopharma
Email Address
0
Founder
‌
John Richard
‌
Denise Scots-Knight
‌
Charles Sermon
Full Address
800 Chesapeake Dr Redwood City CA 94063 United States
0
257 Park Avenue South, 15th Flr. New York, NY, USA
1 Cavendish Place London, W1G 0QF United Kingdom
0
Industry
Biomedical engineering
Biomedical engineering
Research and development
Research and development
Technology
Technology
Cancer
Cancer
Oncology
Oncology
Biology
Biology
Biotechnology
Biotechnology
Internal medicine
Internal medicine
Healthcare
Healthcare
Medicine
Medicine
•••
Investors
Revelation Partners
Revelation Partners
0
LinkedIn URL
@company/mereo-biopharma
Location
Redwood City, California
Redwood City, California
London
London
0
Mountain View, California
Mountain View, California
0
United Kingdom
United Kingdom
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Phone Number
0
Pitchbook URL
pitchbook.com/profiles...120863-71
Place of Incorporation
United Kingdom
United Kingdom
0
SIC Code
2,834
0
Exchange
Nasdaq
Nasdaq
0
Stock Symbol
MREO
0
Ticker Symbol
MREO
Total Funding Amount (USD)
210,100,000
Twitter URL
@mereobiopharma
Official Website
oncomed.com
mereobiopharma.com

Find more companies like Mereo BioPharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.